A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Madelon Q. Wentink; Henk J. Broxterman; Siu W. Lam; Epie Boven; Maudy Walraven; Arjan W. Griffioen; Roberto Pili; Hans J. van der Vliet; Tanja D. de Gruijl; Henk M. W. Verheul

doi:10.1038/bjc.2016.275

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Madelon Q. Wentink, Henk J. Broxterman, Siu W. Lam, Epie Boven, Maudy Walraven, Arjan W. Griffioen, Roberto Pili, Hans J. van der Vliet, Tanja D. de Gruijl, Henk M. W. Verheul

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	940-948
Journal	British Journal of Cancer
Volume	115
Issue number	8
DOIs	https://doi.org/10.1038/bjc.2016.275
Publication status	Published - 11 Oct 2016

Access to Document

10.1038/bjc.2016.275

Cite this

@article{efd68579814849609dc379816f0c4326,

title = "A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer",

keywords = "bioassay, VEGF, bevacizumab, proliferation assay, angiogenesis, antibody",

author = "Wentink, {Madelon Q.} and Broxterman, {Henk J.} and Lam, {Siu W.} and Epie Boven and Maudy Walraven and Griffioen, {Arjan W.} and Roberto Pili and {van der Vliet}, {Hans J.} and {de Gruijl}, {Tanja D.} and Verheul, {Henk M. W.}",

year = "2016",

month = oct,

day = "11",

doi = "10.1038/bjc.2016.275",

language = "English",

volume = "115",

pages = "940--948",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

AU - Wentink, Madelon Q.

AU - Broxterman, Henk J.

AU - Lam, Siu W.

AU - Boven, Epie

AU - Walraven, Maudy

AU - Griffioen, Arjan W.

AU - Pili, Roberto

AU - van der Vliet, Hans J.

AU - de Gruijl, Tanja D.

AU - Verheul, Henk M. W.

PY - 2016/10/11

Y1 - 2016/10/11

KW - bioassay

KW - VEGF

KW - bevacizumab

KW - proliferation assay

KW - angiogenesis

KW - antibody

U2 - 10.1038/bjc.2016.275

DO - 10.1038/bjc.2016.275

M3 - Article

C2 - 27575850

VL - 115

SP - 940

EP - 948

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 8

ER -